Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Everyday Memory Impairment in PD-related Cognitive Decline [NA]
A clinical trial update describes an active-not-recruiting study investigating everyday memory impairment in Parkinson disease-related cogni…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Multicontext Approach for Cognitive Function in Parkinson Disease [NA]
This document notes a clinical trial investigating a multicontext approach to cognitive function in Parkinson disease, with status not yet r…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Intracranial Recordings to Characterize Action Regulation Mechanisms [NA]
This clinical trial update describes intracranial recordings to characterize action regulation mechanisms in Parkinson disease; enrollment i…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease [NA]
A completed clinical trial evaluating a multicomponent exercise protocol with emphasis on muscle power training for bradykinesia in Parkinso…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core
The update notes an enrolling-by-invitation clinical trial evaluating circuit-based deep brain stimulation for Parkinson's disease, run by t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease [Phase 2]
Phase 2 trial evaluating citalopram as a posterior cortical protective therapy in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: UB-312 in Patients With Synucleinopathies [Phase 1]
Phase 1 trial of UB-312 in synucleinopathies (Parkinson's disease and Multiple System Atrophy) has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. [Phase 2]
A Phase 2 randomized, placebo-controlled trial evaluated pimavanserin for impulse control disorders in Parkinson's disease; the study status…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Terazosin And Metabolic Energetics in Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating terazosin's effects on metabolic energetics in Parkinson's disease; status: not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease [NA]
A completed clinical trial evaluated vibrational therapy to improve gait and balance in Parkinson's disease; results have been posted.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging [NA]
A university-led trial is investigating how alpha-synuclein spreads in Parkinson's disease using blood biomarkers and neuroimaging, with rec…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease [NA]
A clinical trial evaluating the cost-effectiveness of Cue2Walk, an automated freezing-detection and external-cue system, versus usual care i…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease. [NA]
An ongoing clinical study sponsored by the University of Minnesota aims to characterize the pallido-thalamocortical motor pathway’s role in …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: [18F]F-DOPA Imaging in Patients With Autonomic Failure [Phase 1]
Phase 1 imaging trial of [18F]F-DOPA in autonomic failure syndromes (including Parkinson's disease, multiple system atrophy, and dementia wi…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Whole-Body Vibration Exercise in Patients With Parkinson's Disease [NA]
Clinical trial update on whole-body vibration exercise for Parkinson's disease. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Exergaming for Imrpving Upper Limb Functions in Parkinson's Disease [NA]
A clinical trial from the University of Health Sciences Lahore is investigating exergaming to improve upper limb function in people with Par…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating metformin for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Allopregnanolone as a Regenerative Treatment for Parkinson's Disease [Phase 1]
A Phase 1 clinical trial evaluating allopregnanolone as a regenerative treatment for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) [Phase 1, Phase 2]
This is an update on a Phase 1/2a trial of PR001 (LY3884961) in Parkinson disease patients with a GBA1 mutation (PROPEL). The study is curre…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Montelukast in Parkinson Disease [Phase 2, Phase 3]
Montelukast is being evaluated in Phase 2 and Phase 3 trials for Parkinson disease and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Exercise to Improve Sleep in Parkinson's Disease [NA]
A McGill University-led clinical trial is recruiting Parkinson's disease patients to evaluate whether a structured exercise program improves…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism [Phase 2]
This clinical trial registry entry describes a Phase 2 study to evaluate neuroinduced mesenchymal stem cells and mesenchymal stem cell-deriv…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease. [Phase 1]
Phase 1 trial evaluating safety, tolerability, feasibility and preliminary efficacy of NouvNeu001 (human dopaminergic progenitor cell inject…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease [Phase 4]
This clinical trial update reports the termination of a Phase 4 study evaluating safinamide's effect on sleep quality in patients with Parki…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease [Phase 3]
A Phase 3 study evaluating Lecigon, an intestinal levodopa plus entacapone therapy for Parkinson's disease, is currently recruiting. The tri…